|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/34 | (2006.01) |
| G01N 33/66 | (2013.01) | ||
| G01N 30/88 | (2006.01) | ||
| G01N2333/924 | (2013.01) | ||
| G01N 33/66 | (2006.01) | ||
| G01N 33/6854 | (2013.01) | ||
| G01N 33/68 | (2006.01) | ||
| G01N2030/8831 | (2013.01) | ||
| G01N 30/74 | (2006.01) | ||
| C12Q 1/34 | (2013.01) |
| (11) | Number of the document | 3540071 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19155593.7 |
| Date of filing the European patent application | 2015-11-19 | |
| (97) | Date of publication of the European application | 2019-09-18 |
| (45) | Date of publication and mention of the grant of the patent | 2023-09-06 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201462082014 P | 2014-11-19 | US |
| (72) |
CHEMMALIL, Letha , US
|
| (73) |
Amgen Inc. ,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (54) | QUANTITATION OF GLYCAN MOIETY IN RECOMBINANT GLYCOPROTEINS |
| QUANTITATION OF GLYCAN MOIETY IN RECOMBINANT GLYCOPROTEINS |